Mark Timney, Blade Therapeutics chairman (Blade)

Small biotech chaired by ex-Pur­due CEO Mark Tim­ney jumps in­to the SPAC lane

The lat­est biotech SPAC has land­ed, and it’s one fea­tur­ing Pur­due Phar­ma’s for­mer CEO, Mark Tim­ney.

Blade Ther­a­peu­tics an­nounced its plans Mon­day to re­verse merge …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.